Vymedic, LLC
5Patents
5Active
5Granted
45Portfolio score
Filing activity: Oct 30, 2009 → Nov 17, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10478447B2 | Antiviral supplement formulations | Emerging Cross-Sectional Technologies | 1 | Active |
| US9907809B2 | Antiviral supplement formulations | Emerging Cross-Sectional Technologies | 1 | Active |
| US11224606B2 | Antiviral supplement formulations | Emerging Cross-Sectional Technologies | 0 | Active |
| US11826377B2 | Antiviral supplement formulations | Emerging Cross-Sectional Technologies | 0 | Active |
| US9034834B2 | Antiviral supplement formulations | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.